EIRION THERAPEUTICS

eirion-therapeutics-logo

Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.

#SimilarOrganizations #People #Financial #Website #More

EIRION THERAPEUTICS

Industry:
Biotechnology Life Science Pharmaceutical

Founded:
2016-01-01

Address:
Woburn, Massachusetts, United States

Country:
United States

Website Url:
http://www.eirionthera.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
40 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Register.com DNS Network Solutions Sun ONE Web Server Sun ONE Web Server V6.1


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

eikonoklastes-therapeutics-logo

Eikonoklastes Therapeutics

Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.


Current Advisors List

kevin-finney_image

Kevin Finney Vice Chairman Of The Board @ Eirion Therapeutics
Board_member
2016-01-01

Current Employees Featured

not_available_image

Jon Edelson
Jon Edelson Founder, CEO & President @ Eirion Therapeutics
Founder, CEO & President

not_available_image

Mary Senica
Mary Senica SVP Quality & Compliance @ Eirion Therapeutics
SVP Quality & Compliance
2021-02-01

Founder


not_available_image

Jon Edelson

Investors List

gorerange-capital_image

Gore Range Capital

Gore Range Capital investment in Series A - Eirion Therapeutics

haohai-biological-technology_image

Haohai Biological Technology

Haohai Biological Technology investment in Series A - Eirion Therapeutics

kinled_image

Kinled Holding

Kinled Holding investment in Series A - Eirion Therapeutics

Official Site Inspections

http://www.eirionthera.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Eirion Therapeutics"

HOME | Eirion

Aesthetic Medicine and. Medical Dermatology Innovation. Copyright 2025 Eirion Therapeutics, Inc. All rights reserved. bottom of pageSee details»

OUR TEAM - Eirion

Jon Edelson, MD. Chairman, CEO & President Mary Senica, MS. Executive Vice President, Quality Assurance and Compliance . Michael Eppolito, MBA. Senior Vice President, Research …See details»

Eirion Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription …See details»

CONTACT - Eirion

Eirion Therapeutics . 25-K Olympia Avenue | Suite 200 . Woburn, MA 01801 Email: [email protected]See details»

Eirion Therapeutics - LinkedIn

Eirion Therapeutics | 160 followers on LinkedIn. Eirion is developing innovative prescription products for aesthetic medicine and medical dermatology.See details»

Eirion 2025 Company Profile: Valuation, Funding & Investors

Eirion General Information Description. Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary …See details»

Eirion Therapeutics - VentureRadar

Website: http://www.eirionthera.com/ Eirion Therapeutics, Inc. is a privately held, clinical stage biopharmaceutical company that is developing next-generation ...See details»

Eirion Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Explore Eirion Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 3 news, and 1 literature, Technology Platform ...See details»

Eirion Therapeutics, Inc. (Eirion Therapeutics, Inc.) - 药物管线_专 …

Demonstrates Potential for ET-02 to be Significantly More Effective Than Existing Treatments for Hair Loss WOBURN, Mass., Jan. 8, 2025 /PRNewswire/ -- Eirion Therapeutics Inc., a …See details»

Eirion Therapeutics Company Profile | Management and

[email protected]: Eirion Therapeutics Top Competitors. Company Employees Revenue Top technologies; Barbara K Honig, Md. 9: $1.6 M: Verdugo Dermatology. 13: $1.8 M: L …See details»

Eirion Therapeutics - VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»

Eirion Therapeutics - Craft

Eirion Therapeutics is a clinical-stage biopharmaceutical company developing prescription products for aesthetic dermatology. It mainly focuses on treatments for wrinkles, primary …See details»

Jon Edelson, MD - Eirion

Jon Edelson, MD. Chairman, CEO & President Jon Edelson, MD, has been our Chairman, CEO & President since our inception in January 2016. Dr.See details»

Eirion Therapeutics - Overview, News & Similar companies

Jan 25, 2023 www.eirionthera.com. Revenue <$5 Million. Industry Hospitals & Clinics Healthcare . Recent News & Media. Eirion Therapeutics to Present at the 2024 IMCAS WORLD …See details»

Eirion Therapeutics Announces Strategic Agreement for HTL …

To learn more about Eirion: www.eirionthera.com . 2 About HTL HTL is a leading biotech and industrial player in the development and production of innovative, pharmaceutical-grade …See details»

Eirion Therapeutics, Inc. Closes $40 Million Series A Investment …

WOBURN, Mass., March 9, 2021 /PRNewswire/ -- Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»

Eirion Therapeutics, Inc. Closes $40 Million Series A ... - Stem Cell

WOBURN, Mass., March 9, 2021 /PRNewswire/ --Today, Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced a deal with …See details»

Eirion Therapeutics-动脉网

Eirion Therapeutics, Inc.是一家私人控股的临床阶段生物制药公司,正在开发下一代皮肤美容处方产品。Eirion目前拥有丰富的产品线,专注于皱纹、原发性腋毛多汗症、雄激素性脱发和头发 …See details»

PIPELINE - Eirion

Product Candidates . ET-01 Topical Botulinum for Lateral Canthal Lines (Crow’s Feet) and Primary Axillary Hyperhidrosis. ET-01 is a topical botulinum product being developed with the …See details»

Theratechnologies Receives FDA Approval for EGRIFTA WR™ …

New, improved formulation set to replace EGRIFTA SV ®. MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) …See details»

linkstock.net © 2022. All rights reserved